Dr. Matthew Romano, MD
Claim this profileUniversity of Michigan
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
9 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Matthew Romano, MD is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Tendyne Transcatheter Mitral Valve System
for Mitral Regurgitation
Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort. Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.
Recruiting1 award N/A4 criteria
More about Matthew Romano, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Matthew Romano, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Abbott Mitraclip System
- Tendyne Mitral Valve System
- MitraClip System
- HARPOON™ Beating Heart Mitral Valve Repair System
Breakdown of trials Matthew Romano, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Mitral Valve Disease
Tricuspid Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Romano, MD specialize in?
Matthew Romano, MD focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Matthew Romano, MD currently recruiting for clinical trials?
Yes, Matthew Romano, MD is currently recruiting for 4 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Matthew Romano, MD has studied deeply?
Yes, Matthew Romano, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, Abbott Mitraclip System.
What is the best way to schedule an appointment with Matthew Romano, MD?
Apply for one of the trials that Matthew Romano, MD is conducting.
What is the office address of Matthew Romano, MD?
The office of Matthew Romano, MD is located at: University of Michigan, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.